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Background: Little is known about the correlation between modifications in plaque composition at stent edges and the changes in vessel 
geometry. This study sought to evaluate, by serial grey-scale intravascular ultrasound (IVUS) and Virtual Histology™ (VH), the modifications in plaque 
composition at the edges of drug-eluting and bare-metal stents and the correlation of these findings with changes in the measurements of vessel, 
lumen and plaque area at those segments.
Methods: Single-center, prospective and randomized (1:1) evaluation of 40 patients with acute coronary syndrome treated with bare-metal 
(Driver™, n=20 patients) or drug-eluting stents (Cypher™, n=20 patients). IVUS and VH assessments were done post procedure and at 9 months. 
Primary endpoint included the modification in vessel, lumen and plaque area and in the composition of the plaque in the mean time between the 
baseline and follow-up procedure.
Results: At the proximal edge of both drug-eluting and bare-metal stents there was a trend to positive vessel remodeling (Δ=+0.6mm2 vs. Δ= 
+0.4mm2. p=0.13) which compensated the increase in plaque area (Δ=+0.5mm2 with DES vs. Δ=+0.7mm2 with BMS, p=0.10). At the distal edge, 
patients treated with drug-eluting stents had less plaque growth (Δ=+0.2mm2 vs. Δ=+1.1mm2. p<0.001), resulting in a larger lumen area at follow-
up. By VH, there was a marked reduction in the % of fibrotic tissue and necrotic core in both edges of the two stents and a positive correlation was 
seen between increase in % of fibrofatty component and increase in plaque area (r=0.78, p=0.01).
Conclusion: Patients treated with DES experienced less plaque growth, especially at the distal edge of the stents. Modifications in plaque 
composition, with increase in fibrofatty content, might partially explain these findings.
